| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | OGN7X90BT8 |
| InChI Key | YCHYFHOSGQABSW-RTBURBONSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C25H36O4 |
| Molecular Weight | 400.56 |
| AlogP | 6.32 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 66.76 |
| Molecular species | ACID |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 29.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Lipid-like ligand receptor (family A GPCR)
Cannabinoid receptor
|
927 | - | - | 6-32 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Dermatomyositis | 3 | D003882 | ClinicalTrials |
| Scleroderma, Diffuse | 3 | D045743 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 2 | D008180 | ClinicalTrials |
| Cystic Fibrosis | 2 | D003550 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL456341 |
| DrugBank | DB12193 |
| EPA CompTox | DTXSID40900959 |
| FDA SRS | OGN7X90BT8 |
| Guide to Pharmacology | 9772 |
| PDB | AJA |
| PubChem | 3083542 |
| SureChEMBL | SCHEMBL26441 |
| ZINC | ZINC000001905712 |